RG 7129

Drug Profile

RG 7129

Alternative Names: RG-7129; RO-5508887

Latest Information Update: 10 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Roche
  • Class Antidementias; Small molecules
  • Mechanism of Action BACE1 protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Alzheimer's disease

Most Recent Events

  • 17 Oct 2013 Discontinued - Phase-I for Alzheimer's disease (in volunteers) in USA and France (PO)
  • 11 Jun 2013 Roche completes a phase I trial in healthy volunteers in the USA and France (NCT01664143)
  • 04 Mar 2013 Roche suspends enrolment in its phase I trial in healthy volunteers in USA and France (NCT01664143)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top